Meet In CommonNewsRSS feeds

Business

Eli Lilly to Buy Calytrix Bio for Up to $1.5 Billion

Meet in Common connects news with real conversations. Use ThinkMatch to arrange a Roundtable and meet people to discuss this story.

Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.

Source: WSJ.com: US Business

Calytrix Bio, a privately held biotechnology company backed by JPMorgan Chase, is developing therapies aimed at a group of rare blood cancers.

This excerpt comes from the named source. Read the original for the full reporting.

Read the original at WSJ.com: US Business

Featured places to meet in Palo Alto, CA

Explore these places and arrange a conversation through ThinkMatch.

City guide for Palo Alto, CA

Community Poll

News organizations should disclose major financial relationships that could influence their coverage.

Share your view, then see how readers voted. No sign-in required. This poll is shared across stories.

Do you agree or disagree?

Choose one answer

Common Quandary

A Common Quandary to discuss

Another conversation to explore, separate from this news story.

The company allows an $80 dinner. Is ordering the lobster fair game?

During work travel, company policy permits an expensive dinner. A modest option is nearby, but colleagues choose the nicest restaurant because the company can easily afford it and everyone is within the stated limit.

Is following a rule enough when you are spending someone else's money?

Explore this quandary